Immune response to GeneVac-BⓇ (rDNA I.P. hepatitis B vaccine) in vaccinated persons with a standard schedule in Bobo-Dioulasso, Burkina Faso

Nina Genéviève Mathuola Ouattara, Armel Moumouni Sanou, Delphine Napon-Zongo, Abou Coulibaly, Sylviane Korogho, Abdoulaye Dera, Achille S Nikièma, Eric Kyelem, Nawatou Gansoré, Abdoul Kader Ilboudo, Jeoffray Diendéré, Gautier Henri Ouédraogo · 2024

Read Immune response to GeneVac-BⓇ (rDNA I.P. hepatitis B vaccine) in vaccinated persons with a standard schedule in Bobo-Dioulasso, Burkina Faso by Nina Genéviève Mathuola Ouattara, Armel Moumouni Sanou, Delphine Napon-Zongo, Abou Coulibaly, Sylviane Korogho, Abdoulaye Dera, Achille S Nikièma, Eric Kyelem, Nawatou Gansoré, Abdoul Kader Ilboudo, Jeoffray Diendéré, Gautier Henri Ouédraogo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11618024.txt.

Description

Highlights•GeneVac-B® showed an excellent immune response.•Its low cost makes it a good tool to prevent hepatitis B infection.•Post-vaccination evaluation should be considered in persons with comorbidities.Keywords: Hepatitis B, GeneVac-BⓇ, Immune response, Nonresponse factors, Burkina Faso Introduction Hepatitis B virus (HBV) infection remains a significant public health problem worldwide despite the availability of prevention methods and effective antivirals [1].

Catalog record

CREATORNina Genéviève Mathuola Ouattara, Armel Moumouni Sanou, Delphine Napon-Zongo, Abou Coulibaly, Sylviane Korogho, Abdoulaye Dera, Achille S Nikièma, Eric Kyelem, Nawatou Gansoré, Abdoul Kader Ilboudo, Jeoffray Diendéré, Gautier Henri Ouédraogo
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11618024

Browse the full library · About the Tower of Babel